"ELVAX"

SECTION 2: Hazards identification

Potential health effects

ADDITIONAL HEALTH EFFECTS Before using "ELVAX" Resins, read the brochures on the safe handling procedures. ACUTE OR IMMEDIATE EFFECTS: ROUTES OF ENTRY AND SYMPTOMS INGESTION The oral LD-50 in rats using one type of “ELVAX" is in excess of 1000 milligrams per kilogram of body weight. Two week metabolic tests with dogs and rats showed that no significant amount of polymer was retained by the animals. 90-day feeding studies in rats showed that "ELVAX" resins have low toxicity. Slight liver effects were seen in animals fed diets containing 10% "ELVAX"; no effects were seen with diets containing 5% "“ELVAX". bey (Continued) VAX001 Page 2 (continueg) Overall, no important body systems or organ dysfunction occurred at either dose level. SKIN No data are available. However, based on experience with handling these polymers, no unusual dermatitis hazard is expected from routine handling. Molten polymer contacting the skin will cause thermal burns. EYE Mechanical irritation. INHALATION Polymer is not respirable as marketed. At processing temperatures above 204 degrees C, fumes irritating to the eye, nose, and throat may be produced. Exposure may result in redness, tearing, and itching in the eyes together with soreness in the nose and throat with coughing.

Medical Conditions Generally Aggravated by Exposure

BY EXPOSURE None known. Carcinogenicity Information The following components are listed by IARC, NTP,